DrugCard - next generation SaaS for pharmacovigilance
Big database of medical and scientific literature, including local journal sites and publications from EMA, WHO, FDA, MHRA, TGA, PMDA, Swissmedic, and local Health Authorities.
Integration with MedDRA medical dictionary. E2B R2/R3 support. Easy ICSR converting to XML in accordance with international ICH requirements.
Automatic comparison of leaflets for medical use of your medicines and reference products. If any changes are detected, you will receive an immediate notification.
The system complies with FDA CFR 21 Part 11, which sets requirements for electronic records and signatures. We provide a certificate of conformity, so you can officially use the system for EU, US, CIS markets as well.
We use data centers with a certified information security management system according to ISO / IEC 27001:2013 and DigitalOcean SOC 2 Type II.
Since we provide Software as a Service - you get the full access at any time. We guarantee "invisible" system maintenance.
The only SaaS on the market that allows automated medical literature monitoring in any language, not limited to websites and also within:
No need to download and read files yourself now. The system will do it for you.
Request a Demo DrugCard and get free access for two weeks. Experience the benefits of our system, which is already using by leading companies
Leave your email and we will give a presentation and give you free access for two weeks
The system contains built-in support for the necessary functions to ensure GxP activity and good documentation practice. At your service:
Data integrity requirements are met in accordance with the GAMP5 Guide: Records & Data Integrity and CFR 21 Part 11.
Working with DrugCard electronic pharmacovigilance platform for literature monitoring is as easy as 1-2-3
Create a drug's card to start medical literature monitoring
Add keywords, such as trade name, substance or excipients
Review the results. Receive periodic updates about new articles found
A weekly manual medical literature monitoring among 20 sources on 40 drugs is 40 hours a week of work (1 rate of the specialist in pharmacovigilance).